PHILIP JESSEN: Open Payments
NPI 1871977173 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 24 payments from 14 companies in 2025. Trend: 2023 $283 · 2024 $896 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Avita Medical Americas, LLC | 1 | $125 |
| PFIZER INC. | 4 | $79 |
| Lilly USA, LLC | 4 | $67 |
| Amgen Inc. | 4 | $60 |
| Astellas Pharma US Inc | 2 | $34 |
| Seqirus USA Inc | 1 | $32 |
| GENZYME CORPORATION | 1 | $32 |
| Dexcom, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
Products named: Recell, MOUNJARO, NURTEC ODT, Veozah, Flucelvax, OTEZLA, KEVZARA, EVENITY.
Industry payments across FL — which companies pay providers there.
